Treatment of Enterocutaneous Fistula

Classification and Initial Assessment

• Enterocutaneous fistulae are best classified based on their output: low (<200 ml/day), moderate (200-500 ml/day), and high (>500 ml/day) 1
• ECFs usually communicate with segments of active inflammation, often in the context of other complications including intra-abdominal abscess and luminal strictures, or with surgical anastomoses 2
• MRI is the preferred diagnostic tool for enteric fistulas, with the highest sensitivity and specificity 1

Initial Management

• Immediate fluid resuscitation and electrolyte rebalancing is critical, especially for high-output fistulae 1
• Monitor and replace losses, particularly in high-output fistulae which can lead to significant dehydration and electrolyte imbalances 2
• Anti-TNF therapy should only be started after abscesses have been treated with antibiotics and, where possible, drainage 3
• Intra-abdominal abscesses should be treated initially with intravenous antibiotics and radiological drainage when possible 2
• Surgical drainage may be required but immediate resection should be avoided 2

Definitive Management

• Low-volume enterocutaneous fistulae may be controlled with immunomodulator and biological therapy 2, 3
• If a fistula is associated with active inflammation, medical therapy with anti-TNF agents is worthwhile 2
• Anti-TNF therapy has shown limited success with approximately one-third of patients achieving fistula healing 2
• High-volume fistulae usually require surgery to achieve symptom control 2, 3
• Surgery should be planned after stabilization through the four steps: fluid/electrolyte balance, control of sepsis, nutritional improvement, and skin care 1

Special Considerations

• Complexity (multiple tracts) and associated stenosis reduce rates of healing with anti-TNF therapy and increase need for surgery 2
• Increasing complexity of the fistula is associated with adverse outcomes including mortality 2
• If fistulae are associated with bowel stricture and/or abscess, surgery is strongly recommended 1

Skin Care and Negative Pressure Wound Therapy

• Protect skin from fistula output to preserve peri-wound skin integrity 4
• Negative Pressure Wound Therapy (NPWT) may be used to manage output of fistulae and protect surrounding skin 4, 5, 6
• NPWT can help achieve secure bag adhesion and simultaneously manage adjacent wounds 4
• Once output is controlled and a granulating bed achieved, skin grafting may be considered 4

Pitfalls to Avoid

• Initiating anti-TNF therapy before adequate drainage of abscesses can worsen sepsis 3
• Immediate surgical resection without adequate preparation (nutritional optimization, sepsis control) leads to poorer outcomes 2
• Failure to address associated complications (strictures, abscesses) will reduce success rates of both medical and surgical interventions 2
• Neglecting skin care can lead to significant skin breakdown and additional morbidity 4

Management of Enteric Fistulas with Vacuum-Assisted Closure

Indications and Techniques

• The International Journal of Surgery recommends the use of Vacuum-Assisted Closure (VAC) as the best available option for managing enteric fistulas, with the primary goal of controlling effluent and protecting perilesional skin 7, 8
• The VAC system can be used to divert effluent from enteric fistulas, preventing the spread of intra-abdominal sepsis 7, 8
• The system can divert effluent away from the open abdominal wound, although accumulation may occur under the foam depending on viscosity 7, 8
• The VAC system can be used to create a conduit from the source of the effluent to the canister, preventing accumulation 7, 8
• The VAC system can "enthrall" the wound to anchor drainage tubes, ensuring that drainage remains close to the fistula mouth to maximize fluid removal without damaging the intestine 7, 8

Wound Care and Closure

• Visible fistulas can be managed using a "floating stoma" technique, isolating the fistula with an ostomy bag 7, 8
• The VAC system is frequently the only method available for achieving secure adhesion of the bag, particularly in mobile patients 7, 8
• Remote fistulas may require conversion to an enterocutaneous fistula through separate incision and drainage 7, 8

Infection Control and Prevention

• The American Journal of Obstetrics and Gynecology recommends avoiding contamination with feces and urine when applying VAC dressings to vulvar and perineal areas 9
• Solutions include the use of Foley catheters, antimotility agents, rectal tubes, and impermeable dressings 9

Decision Algorithm for VAC Use

• Evaluate the type of fistula: enteric-atmospheric vs. enterocutaneous vs. visible vs. remote 7
• Control sepsis first: drain abscesses before applying VAC 7
• For visible fistulas: apply "floating stoma" technique with ostomy bag and VAC for adhesion 7, 8
• For fistulas with abundant effluent: create a conduit from the source to the canister to prevent accumulation 7, 8

Negative Pressure Wound Therapy for Necrotic Stoma Sites

Clinical Rationale

• NPWT promotes granulation tissue formation in necrotic peristomal wound beds, creating conditions favorable for healing. 10
• The therapy provides a “splinting effect” that stabilizes the wound and anchors drainage tubes close to the stoma opening without causing bowel injury. 11

Technical Application

• Creating a “floating stoma” by isolating the functional stoma with an ostomy bag, combined with NPWT, secures ostomy‑bag adhesion especially in mobile patients. 11
• A non‑adherent interface layer must be placed directly over any exposed bowel or anastomotic tissue before applying NPWT; failure to do so markedly increases the risk of iatrogenic fistula formation. [11][10]

Pressure Settings and Safety

• Continuous negative pressure of 75–125 mmHg effectively drains large volumes of effluent (≈800 mL or more), preventing pooling and maceration of surrounding skin. 12
• Intermittent or variable pressure settings should be avoided because they compromise the splinting effect essential for wound stability. 12
• Foam dressings (not surgical towels or gauze) must be used as the wound filler under NPWT to provide adequate compression and medial traction for closure. 12

Evidence Quality

• The International Journal of Surgery guidelines (2014) assign a Grade B‑D recommendation for NPWT in complex abdominal and stoma wounds, based on multiple case reports and studies demonstrating successful outcomes and reduced surgical‑site infection rates. [11][13][14][12]10

Evidence‑Based Management of Enterocutaneous Fistula

Classification & Imaging

• High‑output enterocutaneous fistulas are defined as those with an output > 500 mL per day, which guides the need for more aggressive medical and surgical strategies. 15
• Magnetic resonance imaging is the preferred modality for delineating fistula anatomy, detecting multiple tracts, associated abscesses, and concurrent bowel strictures because of its superior sensitivity and specificity compared with other imaging techniques. 15

Sepsis Control

• All intra‑abdominal abscesses must be identified and adequately drained before initiating anti‑TNF biologic therapy; commencing biologics without prior drainage markedly increases the risk of sepsis and mortality. [16][17]
• Abscesses should be treated with intravenous antibiotics (e.g., metronidazole + ciprofloxacin) together with percutaneous drainage whenever feasible. [16][17]

Medical Therapy for Crohn‑Related Fistulas

• Anti‑TNF therapy (infliximab 5 mg/kg at weeks 0, 2, 6) may be started only after (1) complete drainage of any abscesses, (2) exclusion of distal bowel obstruction, and (3) confirmation of hemodynamic stability. [16][17]
• Immunomodulators such as azathioprine (1.5–2.5 mg/kg/day) or mercaptopurine (0.75–1.5 mg/kg/day) can be considered for simple enterocutaneous fistulas when both obstruction and abscess have been ruled out. [16][17]

Indications for Surgery

• Failure of conservative (medical) management after an adequate period of optimization is an indication for definitive surgical repair. 15
• In patients with localized colonic disease involving less than one‑third of the colon, resection should be limited to the affected segment rather than a more extensive colectomy. 15

Timing of Definitive Surgery

• A delayed definitive operation, typically performed 6–12 months after initial fistula diagnosis, is recommended to allow resolution of inflammation, lysis of adhesions, and complete wound healing, thereby reducing postoperative failure rates. 15